Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Journal of Clinical Medicine|May 13, 2023
Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort StudyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Liliana Andrade Chebli, et al.Journal of Medical Case Reports|September 14, 2020
Neuroendocrine appendiceal tumor and endometriosis of the appendix: a case reportRogério Serafim Parra, Marley Ribeiro Feitosa, Giovana Bachega Badiale Biagi, et al.Acta Cirurgica Brasileira|April 14, 2017
Analysis of gene expression EGFR and KRAS, microRNA-21 and microRNA-203 in patients with colon and rectal cancer and correlation with clinical outcome and prognostic factorsThais Inácio de Carvalho, Paulo Cezar Novais, Fermino Sanches Lizarte, et al.Pharmaceutics|February 25, 2023
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American StudyLetícia Rodrigues de Souza, Daniela Oliveira Magro, Fábio Vieira Teixeira, et al.Digestive Diseases and Sciences|August 26, 2020
Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel DiseasesSandro da Costa Ferreira, Ibrahim Abiodoun Sadissou, Rogério Serafim Parra, et al.Arquivos De Gastroenterologia|June 10, 2026
EVALUATION OF CLINICAL ASPECTS OF PATIENTS UNDERGOING SACRAL NEUROMODULATION FOR FECAL INCONTINENCE: A RETROSPECTIVE MULTICENTER STUDYHugo Parra de Camargo, Vanessa Foresto Machado, Rogério Serafim Parra, et al.Crohn'S & Colitis 360|April 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational StudyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, et al.BMC Gastroenterology|April 22, 2022
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian studyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, et al.Scientific Reports|February 21, 2024
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIBRenata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria, et al.Gastroenterologia Y Hepatologia|February 23, 2025
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational studySandro da Costa Ferreira, Rogério Serafim Parra, Ligia Yukie Sassaki, et al.Pageof 5